Recurrent genital herpes presents a distinct clinical challenge in people living with HIV, where both the frequency and severity of outbreaks are significantly greater than in the general population.
Both clinical and subclinical reactivations of genital herpes are more frequent in people living with HIV and may lead to persistent and progressive anogenital mucocutaneous lesions, especially with CD4 cell counts below 50 per mm³.
Antiviral therapy is used to manage recurrent episodes in this population. The specific agent and full regimen details are available in the complete structured protocol.
DOI: 10.1111/jdv.20450